HIV-1 infection remains a major public health problem, with an estimated 38.4 million people living with HIV and 1.5 million new HIV infections reported worldwide in 2021. The risk of HIV infection ...

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

Multiple pre-exposure (PrEP) and postexposure (PEP) treatments are now available to prevent HIV infection. An updated Canadian guideline published in CMAJ (Canadian Medical Association Journal) ...

Brazil's Health Regulatory Agency (Anvisa) approved on Monday the use of the drug Sunlenca (lenacapavir) for HIV-1 prevention ...

The Centers for Disease Control and Prevention finalized its guidelines for post-exposure prophylaxis against bacterial sexually transmitted infections on Tuesday. For groups at higher risk of ...

Before Ciarra Covin was diagnosed with HIV in 2008, medications called PrEP (pre-exposure prophylaxis) that prevent HIV infection didn’t exist. As a college student in rural Georgia, Covin found out ...

Investigators examined whether early systemic antibiotic prophylaxis reduces ventilator-associated pneumonia incidence in mechanically ventilated adults with acute brain injury.